Stromal cells in tissue homeostasis: balancing regeneration and fibrosis.
The ageing population and the increasing prevalence of noncommunicable diseases such as diabetes and hypertension have led to an increased prevalence of chronic kidney disease. The generation of de novo kidney tissue from embryonic tissue and stem cells using tissue engineering approaches is being explored as an alternative to renal replacement therapy for treating the disease. It is, however, becoming clear that resident cells can not only induce fibrotic repair, but can also restore damaged kidney tissue. Mobilizing this innate capacity of the kidney to regenerate is of particular interest in the prevention of irreversible kidney failure. A novel concept is that the interaction of interstitial stromal cells with the local immune system may regulate tissue homeostasis and the balance between tissue repair and fibrosis. Mesenchymal stromal cells (MSCs), in particular, may enhance the intrinsic reparative capabilities of the kidney. This Perspectives article considers the innate regenerative potential of the kidney in the context of ongoing studies of MSC therapy.
Division of Nephrology, Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Centre, Postbus 96002300, RC Leiden, Netherlands.
Ton J
TJ
Rabelink
Melissa H
MH
Little
D001854:Bone Marrow Cells / Q000166:cytology; D042783:Endothelial Cells / Q000502:physiology; D005355:Fibrosis; D006706:Homeostasis / Q000502:physiology*; D006801:Humans; D007668:Kidney / Q000473:pathology* / Q000502:physiology*; D007674:Kidney Diseases / Q000628:therapy; D007684:Kidney Tubules / Q000166:cytology; D007963:Leukocytes, Mononuclear / Q000502:physiology; D008264:Macrophages / Q000502:physiology; D012038:Regeneration / Q000502:physiology*; D017154:Stromal Cells / Q000502:physiology*